RKDA vs. NCRA, ORIS, IVP, CEAD, SEED, SANW, SISI, EDBL, AAGR, and YTEN
Should you be buying Arcadia Biosciences stock or one of its competitors? The main competitors of Arcadia Biosciences include Nocera (NCRA), Oriental Rise (ORIS), Inspire Veterinary Partners (IVP), CEA Industries (CEAD), Origin Agritech (SEED), S&W Seed (SANW), Shineco (SISI), Edible Garden (EDBL), African Agriculture (AAGR), and Yield10 Bioscience (YTEN). These companies are all part of the "agriculture" industry.
Arcadia Biosciences vs. Its Competitors
Arcadia Biosciences (NASDAQ:RKDA) and Nocera (NASDAQ:NCRA) are both small-cap agriculture companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, earnings, media sentiment, institutional ownership, analyst recommendations, profitability, dividends and risk.
Nocera has a net margin of -12.70% compared to Arcadia Biosciences' net margin of -38.34%. Arcadia Biosciences' return on equity of -16.94% beat Nocera's return on equity.
17.7% of Arcadia Biosciences shares are held by institutional investors. Comparatively, 1.3% of Nocera shares are held by institutional investors. 1.8% of Arcadia Biosciences shares are held by company insiders. Comparatively, 5.3% of Nocera shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.
Arcadia Biosciences has a beta of 0.5, indicating that its stock price is 50% less volatile than the S&P 500. Comparatively, Nocera has a beta of 1.21, indicating that its stock price is 21% more volatile than the S&P 500.
Arcadia Biosciences presently has a consensus target price of $6.00, indicating a potential upside of 26.32%. Given Arcadia Biosciences' stronger consensus rating and higher possible upside, equities research analysts clearly believe Arcadia Biosciences is more favorable than Nocera.
Nocera has higher revenue and earnings than Arcadia Biosciences. Nocera is trading at a lower price-to-earnings ratio than Arcadia Biosciences, indicating that it is currently the more affordable of the two stocks.
In the previous week, Arcadia Biosciences' average media sentiment score of 0.00 equaled Nocera'saverage media sentiment score.
Summary
Arcadia Biosciences beats Nocera on 8 of the 14 factors compared between the two stocks.
Get Arcadia Biosciences News Delivered to You Automatically
Sign up to receive the latest news and ratings for RKDA and its competitors with MarketBeat's FREE daily newsletter.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Arcadia Biosciences Competitors List
Related Companies and Tools
This page (NASDAQ:RKDA) was last updated on 7/7/2025 by MarketBeat.com Staff
